| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |